SLE patients in the EA‐3 cluster, which showed lower disease activity, also had a significantly lower frequency of U1 RNP/Sm seropositivity and a trend toward lower rates of hypocomplementemia and dsDNA antibody positivity (not significant). Here, U1 is linked to systemic lupus erythematosus.